Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome

Author:

Franco Juan VA1,Turk Tarek2,Jung Jae Hung3,Xiao Yu-Tian4,Iakhno Stanislav5,Tirapegui Federico Ignacio6,Garrote Virginia7,Vietto Valeria8

Affiliation:

1. Instituto Universitario Hospital Italiano; Argentine Cochrane Centre; Potosí 4234 Buenos Aires Buenos Aires Argentina C1199ACL

2. Damascus University; Faculty of Medicine; Mazzeh Street Damascus Syrian Arab Republic

3. Yonsei University Wonju College of Medicine; Department of Urology; 20 Ilsan-ro Wonju Gangwon Korea, South 26426

4. Changhai Hospital, Second Military Medical University; Department of Urology; 168 Changhai Road Shanghai China

5. University of Tromso; 9020 Storbakkvegen 21 Tromsdalen Norway H0101

6. Hospital Italiano de Buenos Aires; Urology Division; Juan D. Peron 4190 Ciudad Autónoma de Buenos Aires Buenos Aires Argentina C1181ACH

7. Instituto Universitario Hospital Italiano; Biblioteca Central; J.D. Perón 4190 Buenos Aires Argentina C1199ABB

8. Hospital Italiano de Buenos Aires; Family and Community Medicine Service; Buenos Aires Argentina

Publisher

Wiley

Subject

Pharmacology (medical)

Reference290 articles.

1. PD62-01 Daily low dose tadalafil in treatment of chronic prostatitis/chronic pelvic pain syndrome: randomized controlled study of efficacy and safety;Abdalla;Journal of Urology,2018

2. Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial;Alexander;Annals of Internal Medicine,2004

3. Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome;Propert;Urology,2002

4. A comparative clinical randomized trial of cernilton efficacy and safety in patients with chronic abacterial prostatitis;Apolikhin;Urologiia,2010

5. Efficacy and safety of pollen extract of several different plants (cernilton) in patients with chronic abacterial prostatitis;Apolikhin;European Urology,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3